Education
About Us
Working with TipRanks
Follow Us
Carasent AB (SE:CARA)
:CARA
CARA Stock Chart & Stats
kr26.20
-kr0.28(-1.22%)
At close: 4:00 PM EST
kr26.20
-kr0.28(-1.22%)
Day’s Range― - ―
52-Week Rangekr19.60 - kr31.25
Previous CloseN/A
Volume42.56K
Average Volume (3M)175.33K
Market Cap
kr1.89B
Enterprise Valuekr1.80B
Total Cash (Recent Filing)kr254.79M
Total Debt (Recent Filing)kr35.32M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Feb 12, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding72,324,780
10 Day Avg. Volume229,351
30 Day Avg. Volume175,329
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Carasent AB News
CARA FAQ
What was Carasent AB’s price range in the past 12 months?
Carasent AB lowest stock price was kr19.60 and its highest was kr31.25 in the past 12 months.
What is Carasent AB’s market cap?
Carasent AB’s market cap is kr1.89B.
When is Carasent AB’s upcoming earnings report date?
Carasent AB’s upcoming earnings report date is Feb 12, 2026 which is in 58 days.
How were Carasent AB’s earnings last quarter?
Carasent AB released its earnings results on Oct 16, 2025. The company reported kr0.2 earnings per share for the quarter, beating the consensus estimate of kr0.06 by kr0.14.
Is Carasent AB overvalued?
According to Wall Street analysts Carasent AB’s price is currently Overvalued.
Does Carasent AB pay dividends?
Carasent AB pays a Notavailable dividend of kr1.84 which represents an annual dividend yield of N/A. See more information on Carasent AB dividends here
What is Carasent AB’s EPS estimate?
Carasent AB’s EPS estimate is 0.12.
How many shares outstanding does Carasent AB have?
Carasent AB has 72,324,780 shares outstanding.
What happened to Carasent AB’s price movement after its last earnings report?
Carasent AB reported an EPS of kr0.2 in its last earnings report, beating expectations of kr0.06. Following the earnings report the stock price went up 8.806%.
Which hedge fund is a major shareholder of Carasent AB?
Currently, no hedge funds are holding shares in SE:CARA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Carasent AB
Carasent AB (CARA) is a Swedish technology company primarily focused on providing innovative digital solutions for the healthcare sector. The company specializes in the development and implementation of electronic health record (EHR) systems, telemedicine platforms, and data analytics tools aimed at improving patient care and operational efficiency. With a commitment to enhancing healthcare delivery, Carasent operates in various sectors, including hospitals, clinics, and outpatient services, delivering products that facilitate better healthcare management and patient engagement.
Technical Analysis
EQL Pharma AB
―
Vicore Pharma Holding AB
―
Humana AB
―
Xspray Pharma AB
―
Sedana Medical AB
―
Options Prices
Currently, No data available
---